162 related articles for article (PubMed ID: 28331027)
1. Malignant hypercalcaemia related to parathyroid hormone-related peptide (PTHrP) secretion from a metastatic pancreatic neuroendocrine tumour (NET).
Symington M; Davies L; Kaltsas G; Weickert MO
BMJ Case Rep; 2017 Mar; 2017():. PubMed ID: 28331027
[TBL] [Abstract][Full Text] [Related]
2. Case report of multimodality treatment for metastatic parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour.
Rossi RE; Naik K; Navalkissoor S; Imber C; O'Beirne J; Toumpanakis C; Caplin ME
Tumori; 2014; 100(4):153e-6e. PubMed ID: 25296608
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemia.
Müssig K; Petersenn S; Wehrmann M; Horger M; Vierling P; Häring HU; Gallwitz B
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):719-23. PubMed ID: 17625444
[TBL] [Abstract][Full Text] [Related]
4. Severe hypercalcemia due to metastatic pancreatic neuroendocrine tumor: a case report.
Behdadnia A; Jeddi M
J Med Case Rep; 2023 Sep; 17(1):400. PubMed ID: 37670372
[TBL] [Abstract][Full Text] [Related]
5. Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers.
Giannetta E; Sesti F; Modica R; Grossrubatscher EM; Guarnotta V; Ragni A; Zanata I; Colao A; Faggiano A
Front Endocrinol (Lausanne); 2021; 12():665698. PubMed ID: 34093441
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumours: case series and literature review.
Srirajaskanthan R; McStay M; Toumpanakis C; Meyer T; Caplin ME
Neuroendocrinology; 2009; 89(1):48-55. PubMed ID: 18679021
[TBL] [Abstract][Full Text] [Related]
7. Humoral hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting neuroendocrine tumors. Report of six cases.
Milanesi A; Yu R; Wolin EM
Pancreatology; 2013; 13(3):324-6. PubMed ID: 23719609
[TBL] [Abstract][Full Text] [Related]
8. Unusual complication of a pancreatic neuroendocrine tumor presenting with malignant hypercalcemia.
Kanakis G; Kaltsas G; Granberg D; Grimelius L; Papaioannou D; Tsolakis AV; Öberg K
J Clin Endocrinol Metab; 2012 Apr; 97(4):E627-31. PubMed ID: 22319031
[TBL] [Abstract][Full Text] [Related]
9. Presentation of a PTHrP-secreting pancreatic neuroendocrine tumour, with hypercalcaemic crisis, pre-eclampsia, and renal failure.
Abraham P; Ralston SH; Hewison M; Fraser WD; Bevan JS
Postgrad Med J; 2002 Dec; 78(926):752-3. PubMed ID: 12509695
[TBL] [Abstract][Full Text] [Related]
10. Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas.
Iliuta IA; Beauregard JM; Couture F; Douville P; Mac-Way F
Clin Nucl Med; 2015 Sep; 40(9):e448-50. PubMed ID: 26053724
[TBL] [Abstract][Full Text] [Related]
11. Protracted hypocalcaemia following a single dose of denosumab in humoral hypercalcaemia of malignancy due to PTHrP-secreting neuroendocrine tumour.
Teng J; Abell S; Hicks RJ; Hofman MS; Sachithanandan N; McKelvie P; MacIsaac RJ
Clin Endocrinol (Oxf); 2014 Dec; 81(6):940-2. PubMed ID: 24890549
[No Abstract] [Full Text] [Related]
12. Pancreatic Neuroendocrine Tumor With Humoral Hypercalcemia and High Tumor PD-L1 Score.
Copur MS; Vargas L; Wedel W; Merani S; Cushman-Vokoun A; Drincic A
Oncology (Williston Park); 2020 Dec; 34(12):548-552. PubMed ID: 33395496
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of two patients with metastatic neuroendocrine tumours treated with octreotide.
van de Loosdrecht AA; van Bodegraven AA; Sepers JM; Sindram JW
Neth J Med; 1998 Sep; 53(3):118-23. PubMed ID: 9803143
[TBL] [Abstract][Full Text] [Related]
14. Hypercalcaemia induced by excessive parathyroid hormone secretion in a patient with a neuroendocrine tumour.
Vacher-Coponat H; Opris A; Denizot A; Dussol B; Berland Y
Nephrol Dial Transplant; 2005 Dec; 20(12):2832-5. PubMed ID: 16188904
[No Abstract] [Full Text] [Related]
15. Intractable hypercalcaemia due to parathyroid hormone-related peptide secretion by a carcinoid tumour.
Mantzoros CS; Suva LJ; Moses AC; Spark R
Clin Endocrinol (Oxf); 1997 Mar; 46(3):373-5. PubMed ID: 9156050
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone-related peptide (PTHrP) secretion by gastroenteropancreatic neuroendocrine tumors (GEP-NETs): clinical features, diagnosis, management, and follow-up.
Kamp K; Feelders RA; van Adrichem RC; de Rijke YB; van Nederveen FH; Kwekkeboom DJ; de Herder WW
J Clin Endocrinol Metab; 2014 Sep; 99(9):3060-9. PubMed ID: 24905065
[TBL] [Abstract][Full Text] [Related]
17. Rare case of pancreatic neuroendocrine tumour presenting as paraneoplastic hypercalcaemia.
Ferrel B; Franko J; Tee MC
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33858893
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone related protein (PTHrP) mediated hypercalcaemia complicating enteropancreatic malignancy in multiple endocrine neoplasia type 1 (MEN 1).
Burgess JR; Wilkinson S; Lowenthal RM
Aust N Z J Med; 2000 Apr; 30(2):280-1. PubMed ID: 10833127
[No Abstract] [Full Text] [Related]
19. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
20. Hypercalcaemia caused by a carcinoid tumour.
Brzozowska MM; Wolmarans L; Conaglen JV
Intern Med J; 2009 Jun; 39(6):415-8. PubMed ID: 19580622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
